Migvis Monduy
Neurology with Special Qualifications in Child Neurology · Miami, FLNPI 1184949182
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (48.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 43 manufacturers reported payments, led by Sarepta Therapeutics, Inc. at 40.7% of the total. Among neurology with special qualifications in child neurology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 536 payments — averaging $351.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sarepta Therapeutics, Inc.$77K
- Biogen$32K
- Catalyst Pharmaceuticals, Inc.$32K
- PTC Therapeutics, Inc.$24K
- Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$8K
- Travere Therapeutics, Inc.$3K
- plus $13K from 37 others
Across 93 payments — averaging $2912.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- CSL Behring$88K
- Travere Therapeutics, Inc.$74K
- Ipsen Biopharmaceuticals, Inc$37K
- Biogen$29K
- Teva Pharmaceuticals USA, Inc.$24K
- Sarepta Therapeutics, Inc.$18K
What the payments were for
- Consulting fees$92,06449%
- Speaking & faculty fees$65,02035%
- Travel & lodging$19,60010%
- Food & beverage$11,3776%
- Education$2000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$188,259 in reported general payments places this provider in the 95th percentile of 137 neurology with special qualifications in child neurology providers in Florida.
See all neurology with special qualifications in child neurology providers in Florida →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 13 | $180 |
Paid to pharmacies, not to this prescriber.
Other neurology with special qualifications in child neurology in Miami
- Trevor ResnickMiami$230K
- Elza VasconcellosMiami$170K
- Ian MillerMiami$104K
- Matt LallasMiami$88K
- Marytery FajardoMiami$44K
- Paula SchleiferMiami$31K
- Roberto Lopez-AlberolaMiami$31K
- Anuj JayakarMiami$24K
- Walter BradleyMiami$19K
- Yashira Torres RamirezMiami$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.